Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8791247Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2024
Linked Award Amount
$2.2M
Full award amounts, FY2024
Award Records
6
Records listing this PI
Award-Linked Rank
#4,442
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Marcus Dasilva Goncalves as a PI. Multi-PI records show the full award amount for context.
- 1OT2CA301505-01OT2The CANcer Cachexia Action Network (CANCAN): a Multidisciplinary Virtual Institute with the Mission to Cure Cancer Cachexia$570.9Kaward amount
- 5R01DK132427-03R01The role of PKM2 in dietary lipid absorption and fructose-induced obesity$540.4Kaward amount
- 7R01CA279561-03R01Combination Therapies Targeting Insulin Signaling in Endometrial Cancer$507.7Kaward amount
- 5R01CA258697-03R01Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell Survival$379.2Kaward amount
- 7R01CA258697-04R01Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell Survival$221Kaward amount
- 5R01CA279561-02R01Combination Therapies Targeting Insulin Signaling in Endometrial Cancer$1award amount
Award organizations
Organizations that administered FY2024 awards listing Marcus Dasilva Goncalves as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardNYU Grossman School of Medicine
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4442
- 2024Entered Top 25% NationallyRanked #4442
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding